A confirmatory phase 3 randomized, double-blind, placebo-controlled study of the safety and effectiveness of immune globulin intravenous (Human), 10% solution (GAMMAGARD LIQUID/KIOVIG) for the treatment of mild to moderate Alzheimer's disease:

✍ Scribed by Lee, Deborah A.; Ngo, Leock Y; Adamiak, Basia; Gelmont, David

• Book ID: 123390089
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 81 KB
• Volume: 7
• Category: Article
• ISSN: 1552-5260
• DOI: 10.1016/j.jalz.2011.05.2250